Leukotriene E4, random urine

Alphabetical Test listing

Leukotriene E4, random urine-994

  
Leukotriene E4, random urine
  
994
  
LAB994
  
MSO
  
Cysteinyl Leukotriene
LTE4
Mast Cell Activation Syndrome
Mastocytosis
Systemic Mast Cell Activation
  

An aid to evaluate patients suspected of having systemic mastocytosis using random urine collections

  
Urine, random
  
  
5 mL
  
2 mL
  
  1. Transfer a 5 mL (minimum 2.0mL) aliquot to a Screw cap transfer vial/tube (Mayo T914), labeled as urine
  
  

Frozen (preferred) – 30 days

Refrigerated - 7 days

Ambient - 24 hours

  
Mayo Clinic Laboratories (RLTE4): R-NX
  
Mo, Th
  
6 days
  

Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS), Enzymatic Colorimetric Assay

  

≤104 pg/mg creatinine

  
Patients taking 5-lipoxygenase inhibitor zileuton/Zyflo may have decreased concentrations of leukotriene E4 (LTE4) if dosage has not been discontinued for 48 hours.

Systemic mastocytosis is a heterogenous disease and lack of elevated LTE4 does not exclude the diagnosis of mast cell disease.

Increased excretion of LTE4 has also been reported in the following conditions: asthma, eosinophilic pneumonia, respiratory syncytial virus infection, atopic dermatitis, Crohn disease, and rheumatoid arthritis.
  
82542
82570
  
03/01/2022
  
02/06/2023
  
03/01/2022